Proteins and peptides from vegetable food sources as therapeutic adjuvants for the type 2 diabetes mellitus

Crit Rev Food Sci Nutr. 2022;62(10):2673-2682. doi: 10.1080/10408398.2020.1857331. Epub 2020 Dec 10.

Abstract

Proteins and peptides are fundamental components of the cereals, pseudocereals, and legumes, giving them numerous health-beneficial properties. Previous studies have demonstrated that these molecules exerted effects on current therapeutic targets related to type 2 diabetes mellitus, such as incretin hormones (responsible for appetite suppression), dipeptidyl peptidase IV (an enzyme involved in the inactivation and degradation of the incretin hormones), and glucose transporters (molecules that transport glucose in or out of cells). Therefore, this review presents the current biological activity of protein derivatives and peptides isolated from cereals, pseudocereals, and legumes on these therapeutic markers, highlighting their potential as a possible pharmacological treatment for type 2 diabetes mellitus.

Keywords: Protein; antidiabetic activity; bioactive peptides; cereals; legumes.

Publication types

  • Review

MeSH terms

  • Diabetes Mellitus, Type 2* / drug therapy
  • Dipeptidyl-Peptidase IV Inhibitors* / chemistry
  • Dipeptidyl-Peptidase IV Inhibitors* / pharmacology
  • Dipeptidyl-Peptidase IV Inhibitors* / therapeutic use
  • Incretins / metabolism
  • Peptides / pharmacology
  • Peptides / therapeutic use
  • Vegetables

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Incretins
  • Peptides